無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

呼吸器診断の世界市場の予測 〜2021年:製品・サービス・検査タイプ (肺機能検査・画像検査)・疾患・エンドユーザー別

Respiratory Diagnostics Market by Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to 2021

発行 MarketsandMarkets 商品コード 396692
出版日 ページ情報 英文 146 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.47円で換算しております。
Back to Top
呼吸器診断の世界市場の予測 〜2021年:製品・サービス・検査タイプ (肺機能検査・画像検査)・疾患・エンドユーザー別 Respiratory Diagnostics Market by Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to 2021
出版日: 2016年11月17日 ページ情報: 英文 146 Pages
概要

世界の呼吸器診断の市場は2016年から2021年にかけて7.3%のCAGR (年間複合成長率) で推移し、2016年の52億4000万米ドルから、2021年には74億5000万米ドルの規模に成長すると予測されています。呼吸器系疾患の有病率の上昇や高齢者人口の増加、技術的進歩などの要因が同市場の成長を推進しています。

当レポートでは、世界の呼吸器診断の市場を調査し、市場および診断検査の概要、市場成長への各種影響因子および市場機会の分析、製品&サービス・検査タイプ・疾患・エンドユーザー・地域別の動向と市場規模の推移と予測、競合環境、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 市場概要:実績・予測
  • 検査タイプ別市場
  • 地域別市場
  • 製品・サービス別市場
  • エンドユーザー別市場
  • 疾患別市場

第5章 呼吸器診断の世界市場:概要

  • イントロダクション
  • 市場力学
    • 呼吸器系疾患の有病率の上昇
    • 高齢者人口の増加
    • 技術的進歩
    • 市場成長阻害因子
    • 市場機会
    • 市場課題

第6章 呼吸器診断の世界市場:製品・サービス別の分析

  • イントロダクション
  • 器具・機器
  • アッセイ・試薬
  • サービス・ソフトウェア

第7章 呼吸器診断の世界市場:検査タイプ別の分析

  • イントロダクション
  • 機械的検査
    • 肺機能検査
      • スパイロメトリー
      • ピークフロー検査
  • 閉塞性睡眠時無呼吸 (OSA) 診断検査
  • その他の検査タイプ
  • 画像検査
    • X線
    • CT
    • MRI
    • PET
    • その他
  • 従来型診断検査
    • 免疫診断
    • 生化学的特徴付け
    • 顕微鏡
  • 分子診断検査
    • PCR
    • 核酸増幅検査
    • in situハイブリダイゼーション
    • DNAシークエンシング&次世代シークエンシング (NGS)
    • マイクロアレイ
    • その他

第8章 呼吸器診断の世界市場:疾患別の分析

  • イントロダクション
  • 結核
  • 喘息
  • 肺癌
  • 慢性閉塞性肺疾患
  • その他

第9章 呼吸器診断の世界市場:エンドユーザー別の分析

  • イントロダクション
  • 病院/臨床ラボ
  • リファレンスラボラトリー
  • 診療所
  • その他

第10章 呼吸器診断の世界市場:地域別の分析

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第11章 競合環境

  • 概要
  • 市場シェア
  • 製品・サービスの投入
  • 法的承認
  • 合意・提携・協力・ジョイントベンチャー・契約
  • 買収
  • 拡張

第12章 企業プロファイル

  • イントロダクション
  • PHILIPS HEALTHCARE
  • BECTON, DICKINSON & COMPANY
  • ABBOTT LABORATORIES
  • THERMO FISHER SCIENTIFIC INC.
  • BIOMERIEUX
  • ALERE INC.
  • BIO-RAD LABORATORIES, INC.
  • COSMED
  • SEEGENE INC.
  • SDI DIAGNOSTICS
    • 概要
    • 製品・サービス
    • 戦略
    • 発展動向、など

第13章 付録

目次
Product Code: MD 4740

The global respiratory diagnostics market is projected to reach USD 7.45 billion by 2021 from USD 5.24 billion in 2016, at a CAGR of 7.3% from 2016 to 2021. Increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in respiratory diagnostic systems are the major factors driving the growth of the global respiratory diagnostics market.

Developing markets in Asia-Pacific such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore offer lucrative opportunities for players in the respiratory diagnostics market. Rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players, and expansion of private-sector hospitals to rural areas in various APAC countries are the major factors driving the growth of the respiratory diagnostics market.

The global respiratory diagnostics market is broadly segmented by product and service, test type, disease, end user, and region. On the basis of product and service, the respiratory diagnostics market is segmented into instruments & devices, assays & reagents, and software & services. The instruments and devices segment is expected to account for the largest share of the respiratory diagnostics market in 2016. This large share can be attributed to the continuous requirement of diagnostic instruments and devices in laboratories, point-of-care, and home care diagnosis.

On the basis of test type, the respiratory diagnostics market is broadly classified into mechanical tests, imaging tests, traditional diagnostic tests, and molecular diagnostic tests. In 2016, the traditional diagnostic tests segment is expected to account for the largest share of the respiratory diagnostics market. The large share of this segment can be primarily attributed to the quick turnaround time of these tests. However, over the years, advancements in technology have led to the replacement of traditional techniques with molecular diagnostic techniques.

On the basis of disease, the respiratory diagnostics market is segmented into asthma, chronic obstructive pulmonary disease, lung cancer, tuberculosis, and other diseases. The tuberculosis segment is expected to account for the largest share of the respiratory diagnostics market in 2016. The large share of this segment can be primarily attributed to the increase in tobacco smoking and growing air pollution levels.

On the basis of end user, the respiratory diagnostics market is categorized into hospital/clinical laboratories, reference laboratories, physician offices, and other end users (including blood banks, point-of-care testing, patient self-testing, home health agencies, nursing homes, and local public health laboratories). In 2016, the hospital/clinical laboratories segment is expected to account for the largest share of the global respiratory diagnostics market. Most respiratory disease diagnostics are carried out in hospitals as they are complex in nature and require technologically advanced products; this is driving the respiratory diagnostics market for hospital/clinical laboratories. Point-of-care diagnostics and patient self-testing are also expected to contribute to the growth of the respiratory diagnostics market in the forecast period due to the increasing demand for convenient testing processes and quick results.

New and innovative product launches was the dominant strategy adopted by key industry participants to increase their market share and cater to unmet needs.

Research Coverage:

From an insight perspective, this research report focuses on qualitative data, market size, and growth of various segments and subsegments, competitive landscape, and company profiles. The qualitative data covers various levels of industry analysis such as market dynamics (drivers, restraints, opportunities, and threats), winning imperatives, and burning issues. The report also offers market sizes and data on the growth of various segments in the industry. It focuses on emerging and high-growth segments, high-growth regions, and initiatives of governments. The competitive landscape covers growth strategies adopted by industry players in the last three years. The company profiles comprise basic views on key players in the respiratory diagnostics market and the product portfolios, developments, and strategies adopted by market players to maintain and increase their market shares in the near future. The abovementioned market research data, current market size, and forecast of future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, change in approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

From an insight perspective, this research report focuses on various levels of analysis-industry analysis (industry trends) and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the respiratory diagnostics market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on products offered by the top players in the respiratory diagnostics market
  • Product Development/Innovation: Detailed insights on the upcoming technologies, research & development activities, and new product launches in the respiratory diagnostics market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for respiratory diagnostics products across various regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the respiratory diagnostics market
  • Competitive Assessment: In-depth assessment of market ranking, strategies, products, and manufacturing capabilities of the leading players in the respiratory diagnostics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. RESPIRATORY DIAGNOSTICS MARKET, BY REGION
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.2.1. KEY DATA FROM SECONDARY SOURCES
    • 2.2.2. KEY DATA FROM PRIMARY SOURCES
      • 2.2.2.1. Key Industry Insights
    • 2.2.3. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. RESPIRATORY DIAGNOSTICS MARKET SNAPSHOT, 2016 VS. 2021
  • 4.2. RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE
  • 4.3. RESPIRATORY DIAGNOSTICS MARKET, BY REGION
  • 4.4. RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE
  • 4.5. RESPIRATORY DIAGNOSTICS MARKET, BY END USER
  • 4.6. RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. RISING PREVALENCE OF RESPIRATORY DISEASES
      • 5.2.1.1. High prevalence of tobacco smoking
      • 5.2.1.2. Changing lifestyles
      • 5.2.1.3. Urbanization and growing pollution levels
    • 5.2.2. RISING GERIATRIC POPULATION
    • 5.2.3. TECHNOLOGICAL ADVANCEMENTS
    • 5.2.4. MARKET RESTRAINTS
      • 5.2.4.1. Reimbursement concerns
      • 5.2.4.2. Rising healthcare costs limiting the usage of novel respiratory diagnostic techniques
    • 5.2.5. MARKET OPPORTUNITIES
      • 5.2.5.1. Growing demand for home care and point-of-care diagnostic devices
      • 5.2.5.2. High growth potential in developing Asia-Pacific countries
    • 5.2.6. MARKET CHALLENGE
      • 5.2.6.1. Lack of awareness and large underdiagnosed and undertreated population

6. RESPIRATORY DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE

  • 6.1. INTRODUCTION
  • 6.2. INSTRUMENTS & DEVICES
  • 6.3. ASSAYS & REAGENTS
  • 6.4. SERVICES & SOFTWARE

7. RESPIRATORY DIAGNOSTICS MARKET, BY TEST TYPE

  • 7.1. INTRODUCTION
  • 7.2. MECHANICAL TESTS
    • 7.2.1. PULMONARY FUNCTION TESTS
      • 7.2.1.1. Spirometry
      • 7.2.1.2. Peak flow test
  • 7.3. OSA DIAGNOSTIC TESTS
  • 7.4. OTHER TEST TYPES
  • 7.5. IMAGING TESTS
    • 7.5.1. X-RAY
    • 7.5.2. COMPUTED TOMOGRAPHY
    • 7.5.3. MAGNETIC RESONANCE IMAGING (MRI)
    • 7.5.4. POSITRON EMISSION TOMOGRAPHY (PET)
    • 7.5.5. OTHER IMAGING TESTS
  • 7.6. TRADITIONAL DIAGNOSTIC TESTS
    • 7.6.1. IMMUNODIAGNOSTICS
    • 7.6.2. BIOCHEMICAL CHARACTERIZATION
    • 7.6.3. MICROSCOPY
  • 7.7. MOLECULAR DIAGNOSTIC TESTS
    • 7.7.1. PCR
    • 7.7.2. NUCLEIC ACID AMPLIFICATION TEST
    • 7.7.3. IN SITU HYBRIDIZATION
    • 7.7.4. DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS)
    • 7.7.5. MICROARRAYS
    • 7.7.6. OTHER MOLECULAR DIAGNOSTIC TESTS

8. RESPIRATORY DIAGNOSTICS MARKET, BY DISEASE

  • 8.1. INTRODUCTION
  • 8.2. TUBERCULOSIS
  • 8.3. ASTHMA
  • 8.4. LUNG CANCER
  • 8.5. CHRONIC OBSTRUCTIVE PULMONARY DISEASE
  • 8.6. OTHER RESPIRATORY DISEASES

9. RESPIRATORY DIAGNOSTICS MARKET, BY END USER

  • 9.1. INTRODUCTION
  • 9.2. HOSPITAL/CLINICAL LABORATORIES
  • 9.3. REFERENCE LABORATORIES
  • 9.4. PHYSICIAN OFFICES
  • 9.5. OTHER END USERS

10. RESPIRATORY DIAGNOSTICS MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
  • 10.3. EUROPE
  • 10.4. ASIA-PACIFIC
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. BATTLE FOR MARKET SHARE: PRODUCT & SERVICE LAUNCHES-KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS
  • 11.3. PRODUCT & SERVICE LAUNCHES
  • 11.4. REGULATORY APPROVALS
  • 11.5. AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, JOINT VENTURES, AND CONTRACTS
  • 11.6. ACQUISITIONS
  • 11.7. EXPANSIONS

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. INTRODUCTION
  • 12.2. PHILIPS HEALTHCARE
  • 12.3. BECTON, DICKINSON & COMPANY
  • 12.4. ABBOTT LABORATORIES
  • 12.5. THERMO FISHER SCIENTIFIC INC.
  • 12.6. BIOMERIEUX
  • 12.7. ALERE INC.
  • 12.8. BIO-RAD LABORATORIES, INC.
  • 12.9. COSMED
  • 12.10. SEEGENE INC.
  • 12.11. SDI DIAGNOSTICS

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. OTHER DEVELOPMENTS
  • 13.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.6. AVAILABLE CUSTOMIZATIONS
  • 13.7. RELATED REPORTS
  • 13.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: TOTAL NUMBER OF DEATHS ASSOCIATED WITH RESPIRATORY DISEASES, 2000 VS. 2012
  • TABLE 2: OVERWEIGHT ADULT POPULATION STATISTICS, BY COUNTRY, 2000 VS. 2014 (% OF TOTAL ADULT POPULATION)
  • TABLE 3: GLOBAL RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCT & SERVICE, 2014-2021 (USD MILLION)
  • TABLE 4: GLOBAL RESPIRATORY DIAGNOSTIC INSTRUMENTS & DEVICES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 5: GLOBAL RESPIRATORY DIAGNOSTIC ASSAYS & REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: GLOBAL RESPIRATORY DIAGNOSTIC SERVICES & SOFTWARE MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
  • TABLE 8: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR MECHANICAL TESTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR MECHANICAL TESTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 10: PULMONARY FUNCTION TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 11: SPIROMETRY TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: PEAK FLOW TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: OSA DIAGNOSTIC TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: OTHER MECHANICAL TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR IMAGING TESTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR IMAGING TESTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 17: X-RAY TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: CT TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: MRI TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: PET TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: OTHER IMAGING TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 22: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: TRADITIONAL DIAGNOSTIC TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 24: IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: BIOCHEMICAL CHARACTERIZATION MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: MICROSCOPY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 29: PCR TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: NUCLEIC ACID AMPLIFICATION TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: IN SITU HYBRIDIZATION TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: DNA SEQUENCING & NGS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 33: MICROARRAYS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: OTHER MOLECULAR DIAGNOSTIC TESTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 36: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR TUBERCULOSIS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR ASTHMA, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR LUNG CANCER, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR COPD, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR OTHER DISEASES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 42: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR HOSPITAL/CLINICAL LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 44: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR PHYSICIAN OFFICES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 45: RESPIRATORY DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 46: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 47: NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 48: NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
  • TABLE 49: NORTH AMERICA: TRADITIONAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 50: NORTH AMERICA: MECHANICAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 51: NORTH AMERICA: IMAGING TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: MOLECULAR DIAGNOSTIC TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 54: NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 55: EUROPE: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 56: EUROPE: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
  • TABLE 57: EUROPE: TRADITIONAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: MECHANICAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 59: EUROPE: IMAGING TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 60: EUROPE: MOLECULAR DIAGNOSTIC TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 61: EUROPE: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 62: EUROPE: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 63: ASIA-PACIFIC: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 64: ASIA-PACIFIC: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
  • TABLE 65: ASIA-PACIFIC: TRADITIONAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 66: ASIA-PACIFIC: MECHANICAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 67: ASIA-PACIFIC: IMAGING TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 68: ASIA-PACIFIC: MOLECULAR DIAGNOSTIC TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 69: ASIA-PACIFIC: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 70: ASIA-PACIFIC: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 71: ROW: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCTS AND SERVICES, 2014-2021 (USD MILLION)
  • TABLE 72: ROW: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: ROW: TRADITIONAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 74: ROW: MECHANICAL TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 75: ROW: IMAGING TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 76: ROW: MOLECULAR DIAGNOSTIC TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 77: ROW: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2014-2021 (USD MILLION)
  • TABLE 78: ROW: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 79: PRODUCT & SERVICE LAUNCHES, 2014-2016
  • TABLE 80: REGULATORY APPROVALS, 2014-2016
  • TABLE 81: AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, JOINT VENTURES, AND CONTRACTS, 2014-2016
  • TABLE 82: ACQUISITIONS, 2014-2016
  • TABLE 83: EXPANSIONS, 2014-2016

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: RESPIRATORY DIAGNOSTICS MARKET: TOP DOWN APPROACH
  • FIGURE 3: RESPIRATORY DIAGNOSTICS MARKET: BOTTOM UP APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: MARKET DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: RESPIRATORY DIAGNOSTICS MARKET SNAPSHOT, 2016 VS. 2021
  • FIGURE 7: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY PRODUCTS & SERVICES, 2016 VS. 2021
  • FIGURE 8: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2016 VS. 2021
  • FIGURE 9: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY END USER, 2016 VS. 2021
  • FIGURE 10: RESPIRATORY DIAGNOSTICS MARKET SIZE, BY DISEASE, 2016 VS. 2021
  • FIGURE 11: GEOGRAPHICAL SNAPSHOT OF THE RESPIRATORY DIAGNOSTICS MARKET
  • FIGURE 12: INCREASING PREVALENCE OF RESPIRATORY DISEASES, AN IMPORTANT GROWTH DRIVER
  • FIGURE 13: MECHANICAL TESTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
  • FIGURE 14: ASIA-PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 15: THE INSTRUMENTS AND DEVICES SEGMENT TO DOMINATE THE RESPIRATORY DIAGNOSTICS PRODUCTS & SERVICES MARKET IN 2016
  • FIGURE 16: HOSPITAL/CLINICAL LABORATORIES, THE LARGEST END USERS OF THE RESPIRATORY DIAGNOSTICS MARKET IN 2016
  • FIGURE 17: THE TUBERCULOSIS DISEASE SEGMENT TO DOMINATE THE RESPIRATORY DIAGNOSTICS DISEASE MARKET IN 2016
  • FIGURE 18: RESPIRATORY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 19: COPD AND ASTHMA PREVALENCE, BY COUNTRY, 2014
  • FIGURE 20: SMOKING PREVALENCE, BY COUNTRY, 2010 (% OF TOTAL POPULATION)
  • FIGURE 21: GLOBAL GERIATRIC POPULATION, BY REGION
  • FIGURE 22: INSTRUMENTS & DEVICES TO DOMINATE THE RESPIRATORY DIAGNOSTICS MARKET IN 2016
  • FIGURE 23: TRADITIONAL DIAGNOSTIC TESTS TO DOMINATE THE RESPIRATORY DIAGNOSTICS MARKET DURING THE FORECAST PERIOD
  • FIGURE 24: TUBERCULOSIS SEGMENT TO DOMINATE THE RESPIRATORY DIAGNOSTICS MARKET IN 2016
  • FIGURE 25: HOSPITAL/CLINICAL LABORATORIES TO DOMINATE THE RESPIRATORY DIAGNOSTICS MARKET IN 2016
  • FIGURE 26: ASIA-PACIFIC MARKET PROJECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 27: NORTH AMERICA: RESPIRATORY DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 28: INSTRUMENTS/DEVICES SEGMENT TO DOMINATE THE RESPIRATORY DIAGNOSTIC PRODUCTS AND SERVICES MARKET IN NORTH AMERICA
  • FIGURE 29: ASIA-PACIFIC: RESPIRATORY DIAGNOSTICS MARKET SNAPSHOT
  • FIGURE 30: COMPANIES MAJORLY PURSUED THE STRATEGY OF PRODUCT & SERVICE LAUNCHES BETWEEN 2014 AND 2016
  • FIGURE 31: GEOGRAPHIC REVENUE MIX OF THE TOP FIVE MARKET PLAYERS
  • FIGURE 32: COMPANY SNAPSHOT: PHILIPS HEALTHCARE
  • FIGURE 33: COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY
  • FIGURE 34: COMPANY SNAPSHOT: ABBOTT LABORATORIES
  • FIGURE 35: COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC.
  • FIGURE 36: COMPANY SNAPSHOT: BIOMERIEUX
  • FIGURE 37: COMPANY SNAPSHOT: ALERE INC.
  • FIGURE 38: COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC.
  • FIGURE 39: COMPANY SNAPSHOT: SEEGENE INC.
Back to Top